Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Muggia

Showing results (341-350 of 424) with videos related to

Pageof 43
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996
Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracilF M Muggia, X Wu, D Spicer, et al.
Annals of Surgery|January 1, 1986
Branched chain amino acid-enriched solutions in the septic patient. A randomized, prospective trialR H Bower, M Muggia-Sullam, S Vallgren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studiesB Uziely, S Jeffers, R Isacson, et al.
Cancer|October 1, 1972
Clinical study with bleomycin: tolerance to twice weekly dosageT Onuma, O S Selawry, J F Holland, et al.
Anti-Cancer Drugs|June 1, 1992
High incidence of coagualopathy in phase II studies of recombinant tumor necrosis factor in advanced pancreatic and gastric cancersF M Muggia, T D Brown, P J Goodman, et al.
Anticancer Research|January 1, 1981
Clinical trials with diglycoaldehyde (NSC-118994): review and reasons for withdrawal from clinical trialD F Chiuten, G J Vosika, M T Shaw, et al.
Cancer Treatment Reports|September 1, 1979
Toxic effects of cis-dichlorodiammineplatinum(II) in manD D Von Hoff, R Schilsky, C M Reichert, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1985
Down's syndrome and testicular cancer: a possible associationD L Braun, M D Green, A R Rausen, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1996
Abdomino-pelvic hyperthermia and intraperitoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance and pharmacologyS C Formenti, P N Shrivastava, M Sapozink, et al.
Cancer Treatment Reports|March 1, 1987
Weekly 5-fluorouracil combined with PALA: toxic and therapeutic effects in colorectal cancerF M Muggia, F J Camacho, B H Kaplan, et al.
Pageof 43

Showing results (341-350 of 424) with videos related to

Sort By:
Pageof 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996
Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracilF M Muggia, X Wu, D Spicer, et al.
Annals of Surgery|January 1, 1986
Branched chain amino acid-enriched solutions in the septic patient. A randomized, prospective trialR H Bower, M Muggia-Sullam, S Vallgren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studiesB Uziely, S Jeffers, R Isacson, et al.
Cancer|October 1, 1972
Clinical study with bleomycin: tolerance to twice weekly dosageT Onuma, O S Selawry, J F Holland, et al.
Anti-Cancer Drugs|June 1, 1992
High incidence of coagualopathy in phase II studies of recombinant tumor necrosis factor in advanced pancreatic and gastric cancersF M Muggia, T D Brown, P J Goodman, et al.
Anticancer Research|January 1, 1981
Clinical trials with diglycoaldehyde (NSC-118994): review and reasons for withdrawal from clinical trialD F Chiuten, G J Vosika, M T Shaw, et al.
Cancer Treatment Reports|September 1, 1979
Toxic effects of cis-dichlorodiammineplatinum(II) in manD D Von Hoff, R Schilsky, C M Reichert, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1985
Down's syndrome and testicular cancer: a possible associationD L Braun, M D Green, A R Rausen, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1996
Abdomino-pelvic hyperthermia and intraperitoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance and pharmacologyS C Formenti, P N Shrivastava, M Sapozink, et al.
Cancer Treatment Reports|March 1, 1987
Weekly 5-fluorouracil combined with PALA: toxic and therapeutic effects in colorectal cancerF M Muggia, F J Camacho, B H Kaplan, et al.
Pageof 43